China Resources Sanjiu Medical & Pharmaceutical Co Ltd Asset Resilience Ratio
China Resources Sanjiu Medical & Pharmaceutical Co Ltd asset resilience ratio. China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) has an Asset Resilience Ratio of 7.22% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 000999 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of China Resources Sanjiu Medical & Pharmaceutical Co Ltd (2002–2025)
Asset resilience ratio of China Resources Sanjiu Medical & Pharmaceutical Co Ltd from 2002 to 2025. This chart shows how China Resources Sanjiu Medical & Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read total liabilities of China Resources Sanjiu Medical & Pharmac for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down China Resources Sanjiu Medical & Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see China Resources Sanjiu Medical & Pharmac balance sheet assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥4.03 Billion | 7.22% |
| Total Liquid Assets | CN¥4.03 Billion | 7.22% |
Asset Resilience Insights
- Limited Liquidity: China Resources Sanjiu Medical & Pharmaceutical Co Ltd maintains only 7.22% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio
Compare China Resources Sanjiu Medical & Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276 |
Drug Manufacturers - Specialty & Generic | 0.16% |
|
Sandoz Group AG
SW:SDZ |
Drug Manufacturers - Specialty & Generic | 7.89% |
|
H Lundbeck A/S
CO:HLUN-B |
Drug Manufacturers - Specialty & Generic | -0.56% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 47.16% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Viyash Scientific Limited
NSE:SEQUENT |
Drug Manufacturers - Specialty & Generic | 0.08% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Asset Resilience Ratio by Year (2002–2025)
China Resources Sanjiu Medical & Pharmaceutical Co Ltd asset resilience ratio by year from 2002 to 2025. The table below shows the annual Asset Resilience Ratio data for China Resources Sanjiu Medical & Pharmaceutical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 8.32% | CN¥4.89 Billion ≈ $716.13 Million |
CN¥58.80 Billion ≈ $8.60 Billion |
+4.14pp |
| 2024-12-31 | 4.18% | CN¥1.68 Billion ≈ $245.45 Million |
CN¥40.08 Billion ≈ $5.87 Billion |
+0.56pp |
| 2023-12-31 | 3.63% | CN¥1.46 Billion ≈ $213.06 Million |
CN¥40.15 Billion ≈ $5.87 Billion |
-1.34pp |
| 2021-12-31 | 4.97% | CN¥1.22 Billion ≈ $178.35 Million |
CN¥24.54 Billion ≈ $3.59 Billion |
+4.06pp |
| 2020-12-31 | 0.90% | CN¥200.18 Million ≈ $29.29 Million |
CN¥22.15 Billion ≈ $3.24 Billion |
-2.05pp |
| 2016-12-31 | 2.95% | CN¥400.00 Million ≈ $58.53 Million |
CN¥13.55 Billion ≈ $1.98 Billion |
-4.12pp |
| 2015-12-31 | 7.07% | CN¥850.00 Million ≈ $124.38 Million |
CN¥12.02 Billion ≈ $1.76 Billion |
-3.24pp |
| 2014-12-31 | 10.31% | CN¥1.10 Billion ≈ $160.96 Million |
CN¥10.67 Billion ≈ $1.56 Billion |
+4.30pp |
| 2013-12-31 | 6.01% | CN¥600.00 Million ≈ $87.80 Million |
CN¥9.98 Billion ≈ $1.46 Billion |
+5.94pp |
| 2006-12-31 | 0.08% | CN¥5.65 Million ≈ $827.07K |
CN¥7.13 Billion ≈ $1.04 Billion |
+0.00pp |
| 2005-12-31 | 0.08% | CN¥5.33 Million ≈ $780.39K |
CN¥7.04 Billion ≈ $1.03 Billion |
+0.00pp |
| 2002-12-31 | 0.07% | CN¥5.02 Million ≈ $734.12K |
CN¥6.85 Billion ≈ $1.00 Billion |
-- |
About China Resources Sanjiu Medical & Pharmaceutical Co Ltd
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People's Republic of China and internationally. The company offers health consumer products (CHC), including cold, flu, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug prod… Read more